Update on Phase I trial of PBI-05204: ASCO annual meeting poster presentation with discussion. Update on Phase I trial of PBI-05204: ASCO annual meeting poster presentation with discussion. Update on Phase I trial of PBI-05204: ASCO annual meeting poster presentation with discussion.[email protected]2023-12-04T17:19:13-06:00May 6, 2009|
Publication: Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside. Newman RA, Kondo Y, Yokoyama T, Dixon S, Cartwright C, Chan D, Johansen M, Yang P. Integr. Cancer Ther. Publication: Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside. Newman RA, Kondo Y, Yokoyama T, Dixon S, Cartwright C, Chan D, Johansen M, Yang P. Integr. Cancer Ther. Publication: Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside. Newman RA, Kondo Y, Yokoyama T, Dixon S, Cartwright C, Chan D, Johansen M, Yang P. Integr. Cancer Ther.[email protected]2023-12-04T17:19:18-06:00December 6, 2007|
Phoenix enters into contract with Quintiles, Inc. to act as Clinical Research Organization for “An Open Label Phase I Trial of PBI-05204 in Advanced Cancer Patients” to be conducted at M. D. Anderson Cancer Center. Phoenix enters into contract with Quintiles, Inc. to act as Clinical Research Organization for “An Open Label Phase I Trial of PBI-05204 in Advanced Cancer Patients” to be conducted at M. D. Anderson Cancer Center. Phoenix enters into contract with Quintiles, Inc. to act as Clinical Research Organization for “An Open Label Phase I Trial of PBI-05204 in Advanced Cancer Patients” to be conducted at M. D. Anderson Cancer Center.[email protected]2023-12-04T17:19:23-06:00January 6, 2007|
Focus on Health: Oleander plant shows promise as cancer-fighter Focus on Health: Oleander plant shows promise as cancer-fighter Focus on Health: Oleander plant shows promise as cancer-fighter[email protected]2023-12-04T17:19:28-06:00June 22, 2005|